✨
AI Summary
- Joan Shen discusses CNS drug development in China with NeuShen.
- Business rationale, challenges, and fundraising for CNS therapies.
- Updates on schizophrenia, epilepsy assets and ALS gene therapy collaboration.
Guests on This Episode
NS
NeuShen's Joan Huaqiong Shen
1 podcast appearance